Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry

Date: December 28, 2012
Pages: 251
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: SDB11CF97D9EN
Leaflet:

Download PDF Leaflet

Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry
Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData’s new report, “Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the Saudi Arabia In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology Culture and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Market size and company share data for In Vitro Diagnostics market categories – Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology Culture and Genetic Testing.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.
  • 2011 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the Saudi Arabia In Vitro Diagnostics market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Inc., bioMerieux S.A., Becton, Dickinson and Company and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Saudi Arabia In Vitro Diagnostics competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What is This Report About?

3 IN VITRO DIAGNOSTICS IN SAUDI ARABIA

3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018
3.3 In Vitro Diagnostics Market, Saudi Arabia, Revenue Mix ($m), 2011
3.4 In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2011
3.5 In Vitro Diagnostics, Saudi Arabia, Company Share (2010-2011)

4 CLINICAL CHEMISTRY IN SAUDI ARABIA

4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2011
4.3 Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011
4.4 Clinical Chemistry Overall Revenue, (2004-2018)
  4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018)
  4.4.2 Urine Analysis, Revenue (2004-2018)
4.5 Clinical Chemistry Distribution Share (2010-2011)
4.6 Clinical Chemistry, Saudi Arabia, Company Share (2010-2011)

5 GENETIC TESTING IN SAUDI ARABIA

5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, Saudi Arabia, Revenue Mix ($m), 2011
5.3 Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2011
5.4 Genetic Testing Overall Revenue, (2004-2018)
5.5 Genetic Testing Distribution Share (2010-2011)
5.6 Genetic Testing, Saudi Arabia, Company Share (2010-2011)

6 HAEMATOLOGY IN SAUDI ARABIA

6.1 Haematology Market, Market Segmentation
6.2 Haematology Market, Saudi Arabia, Revenue Mix ($m), 2011
6.3 Haematology Market, Saudi Arabia, Segment Contribution (%), 2011
6.4 Haematology Overall Revenue, (2004-2018)
  6.4.1 Haematology Reagents, Revenue (2004-2018)
  6.4.2 Immunohaematology, Revenue (2004-2018)
  6.4.3 Haemostasis, Revenue (2004-2018)
  6.4.4 Haematology Rapid Tests, Revenue (2004-2018)
  6.4.5 Haematology Cell Counters, Revenue (2004-2018)
6.5 Haematology Distribution Share (2010-2011)
6.6 Haematology, Saudi Arabia, Company Share (2010-2011)

7 HISTOLOGY AND CYTOLOGY IN SAUDI ARABIA

7.1 Histology and Cytology Market, Market Segmentation
7.2 Histology And Cytology Market, Saudi Arabia, Revenue Mix ($m), 2011
7.3 Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2011
7.4 Histology And Cytology Overall Revenue, (2004-2018)
7.5 Histology And Cytology Distribution Share (2010-2011)
7.6 Histology And Cytology, Saudi Arabia, Company Share (2010-2011)

8 IMMUNO CHEMISTRY IN SAUDI ARABIA

8.1 Immuno Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2011
8.2 Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011
8.3 Immuno Chemistry Overall Revenue, (2004-2018)
  8.3.1 Disease Specific Immunochemistry, Revenue (2004-2018)
  8.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018)
  8.3.3 Endocrinology Tests, Revenue (2004-2018)
  8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018)
  8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018)
  8.3.6 Immunochemistry Analyzers, Revenue (2004-2018)
8.4 Immuno Chemistry Distribution Share (2010-2011)
8.5 Immuno Chemistry, Saudi Arabia, Company Share (2010-2011)

9 INFECTIOUS IMMUNOLOGY IN SAUDI ARABIA

9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, Saudi Arabia, Revenue Mix ($m), 2011
9.3 Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2011
9.4 Infectious Immunology Overall Revenue, (2004-2018)
  9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018)
9.5 Infectious Immunology Distribution Share (2010-2011)
9.6 Infectious Immunology, Saudi Arabia, Company Share (2010-2011)

10 MICROBIOLOGY CULTURE IN SAUDI ARABIA

10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, Saudi Arabia, Revenue Mix ($m), 2011
10.3 Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2011
10.4 Microbiology Culture Overall Revenue, (2004-2018)
  10.4.1 Microbiology Analyzers, Revenue (2004-2018)
10.5 Microbiology Culture Distribution Share (2010-2011)
10.6 Microbiology Culture, Saudi Arabia, Company Share (2010-2011)

11 OVERVIEW OF KEY COMPANIES IN SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET

11.1 F. Hoffmann-La Roche Ltd.
  11.1.1 Company Overview
  11.1.2 Share in the Saudi Arabia In Vitro Diagnostics Market
11.2 Siemens Healthcare
  11.2.1 Company Overview
  11.2.2 Share in the Saudi Arabia In Vitro Diagnostics Market
11.3 Abbott Laboratories
  11.3.1 Company Overview
  11.3.2 Share in the Saudi Arabia In Vitro Diagnostics Market
11.4 Beckman Coulter, Inc.
  11.4.1 Company Overview
  11.4.2 Share in the United States In Vitro Diagnostics Market
11.5 bioMerieux S.A.
  11.5.1 Company Overview
  11.5.2 Share in the Saudi Arabia In Vitro Diagnostics Market
11.6 Becton, Dickinson and Company
  11.6.1 Company Overview
  11.6.2 Share in the Saudi Arabia In Vitro Diagnostics Market
11.7 Ortho-Clinical Diagnostics Inc.
  11.7.1 Company Overview
11.8 Mindray Medical International Limited
  11.8.1 Company Overview
11.9 Bio-Rad Laboratories, Inc.
  11.9.1 Company Overview
11.10 Sysmex Corporation
  11.10.1 Company Overview
11.11 Qiagen N.V.
  11.11.1 Company Overview
11.12 Thermo Fisher Scientific Inc.
  11.12.1 Company Overview
11.13 Grifols, S.A.
  11.13.1 Company Overview
11.14 Horiba, Ltd.
  11.14.1 Company Overview
11.15 PerkinElmer, Inc.
  11.15.1 Company Overview
11.16 Life Technologies Corporation
  11.16.1 Company Overview
11.17 Phadia AB
  11.17.1 Company Overview
11.18 DiaSorin S.p.A
  11.18.1 Company Overview
11.19 Gen-Probe Incorporated
  11.19.1 Company Overview
11.20 Diagnostica Stago, Inc.
  11.20.1 Company Overview
11.21 Chembio Diagnostics, Inc.
  11.21.1 Company Overview
11.22 Alere Inc.
  11.22.1 Company Overview
11.23 Immucor, Inc.
  11.23.1 Company Overview
11.24 Hologic, Inc.
  11.24.1 Company Overview

12 IN VITRO DIAGNOSTICS MARKET PIPELINE PRODUCTS

12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology And Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products

13 FINANCIAL DEALS LANDSCAPE

13.1 Partnerships
  13.1.1 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
  13.1.2 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
  13.1.3 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
  13.1.4 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
  13.1.5 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
  13.1.6 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
  13.1.7 Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
  13.1.8 CML HealthCare Enters Into Agreement With MaRS Innovation
  13.1.9 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
  13.1.10 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
  13.1.11 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
  13.1.12 NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
  13.1.13 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
  13.1.14 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
  13.1.15 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
  13.1.16 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
  13.1.17 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
  13.1.18 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
  13.1.19 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
  13.1.20 One Lambda Enters Into Co-Marketing Agreement With CellTrend
  13.1.21 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
  13.1.22 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
  13.1.23 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker
  13.1.24 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology
  13.1.25 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA
  13.1.26 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange PCR Kit
  13.1.27 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo
  13.1.28 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For Pressure Cycling Technology
  13.1.29 LipoScience Enters Into Licensing Agreement With Cleveland Clinic
  13.1.30 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact Cyclotron And PET Tracer System
  13.1.31 NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers
  13.1.32 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX

14 APPENDIX

14.1 Definitions of Markets Covered in the Report
  14.1.1 In Vitro Diagnostics
14.2 Research Methodology
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Forecasts
14.7 Expert Panels
14.8 GlobalData Consulting
14.9 Currency Conversion
14.10 Contact Us
14.11 Disclaimer

LIST OF TABLES

Table 1: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2011
Table 3: In Vitro Diagnostics Market, Saudi Arabia, Cross-Category Analysis, 2004-2018
Table 4: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: In Vitro Diagnostics, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 7: Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011
Table 8: Clinical Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 9: Clinical Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 10: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 11: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 12: Urine Analysis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 13: Urine Analysis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 14: Clinical Chemistry, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: Clinical Chemistry, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2011
Table 17: Genetic Testing, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Genetic Testing, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Genetic Testing, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 20: Genetic Testing, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 21: Haematology Market, Saudi Arabia, Segment Contribution (%), 2011
Table 22: Haematology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 23: Haematology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 24: Haematology Reagents, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 25: Haematology Reagents, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 26: Immunohaematology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 27: Immunohaematology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 28: Haemostasis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 29: Haemostasis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 30: Haematology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 31: Haematology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 32: Haematology Cell Counters, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 33: Haematology Cell Counters, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 34: Haematology, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 35: Haematology, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 36: Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2011
Table 37: Histology And Cytology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 38: Histology And Cytology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 39: Histology And Cytology, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 40: Histology And Cytology, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011
Table 42: Immuno Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 43: Immuno Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 44: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 45: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 46: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 47: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 48: Endocrinology Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 49: Endocrinology Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 50: Immunochemistry Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 51: Immunochemistry Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 52: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 53: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 54: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 55: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 56: Immuno Chemistry, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 57: Immuno Chemistry, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 58: Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2011
Table 59: Infectious Immunology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 60: Infectious Immunology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 61: Infectious Immunology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 62: Infectious Immunology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 63: Infectious Immunology, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 64: Infectious Immunology, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 65: Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2011
Table 66: Microbiology Culture, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 67: Microbiology Culture, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 68: Microbiology Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 69: Microbiology Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 70: Microbiology Culture, Saudi Arabia, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 71: Microbiology Culture, Saudi Arabia, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 72: Clinical Chemisty Market Pipeline Products
Table 73: Immuno Chemistry Market Pipeline Products
Table 74: Haematology Market Pipeline Products
Table 75: Infectious Immunology Market Pipeline Products
Table 76: Microbiology Culture Market Pipeline Products
Table 77: Histology And Cytology Market Pipeline Products
Table 78: Genetic Testing Market Pipeline Products
Table 79: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For Archimedes Particle Metrology System
Table 80: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ
Table 81: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology Assays
Table 82: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital Microscopy Hematology Solutions
Table 83: Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress Dx Test
Table 84: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
Table 85: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
Table 86: CML HealthCare Enters Into Agreement With MaRS Innovation
Table 87: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women's Hospital For Mesothelioma Test
Table 88: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein Array Products
Table 89: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North Carolina
Table 90: NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype DX Tests
Table 91: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB Test
Table 92: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For PhenoFluor
Table 93: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International
Table 94: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
Table 95: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
Table 96: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis
Table 97: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC Test
Table 98: One Lambda Enters Into Co-Marketing Agreement With CellTrend
Table 99: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For ALK Cancer Biomarker
Table 100: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems
...

LIST OF FIGURES

Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: In Vitro Diagnostics Market, Saudi Arabia, Revenue Mix ($m), 2011
Figure 4: In Vitro Diagnostics Market, Saudi Arabia, Category Contribution (%), 2011
Figure 5: In Vitro Diagnostics Market, Saudi Arabia, Cross-Category Analysis, 2004-2018
Figure 6: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: In Vitro Diagnostics, Saudi Arabia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: In Vitro Diagnostics, Saudi Arabia, Company Share (%), 2011
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2011
Figure 11: Clinical Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011
Figure 12: Clinical Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: Clinical Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 15: Clinical Chemisty Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 16: Urine Analysis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 17: Urine Analysis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 18: Clinical Chemistry, Saudi Arabia, Company Share (%), 2011
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, Saudi Arabia, Revenue Mix ($m), 2011
Figure 21: Genetic Testing Market, Saudi Arabia, Segment Contribution (%), 2011
Figure 22: Genetic Testing, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 23: Genetic Testing, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 24: Genetic Testing, Saudi Arabia, Company Share (%), 2011
Figure 25: Haematology Market, Market Segmentation
Figure 26: Haematology Market, Saudi Arabia, Revenue Mix ($m), 2011
Figure 27: Haematology Market, Saudi Arabia, Segment Contribution (%), 2011
Figure 28: Haematology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 29: Haematology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 30: Haematology Reagents, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 31: Haematology Reagents, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 32: Immunohaematology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 33: Immunohaematology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 34: Haemostasis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 35: Haemostasis, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 36: Haematology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 37: Haematology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 38: Haematology Cell Counters, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 39: Haematology Cell Counters, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 40: Haematology, Saudi Arabia, Company Share (%), 2011
Figure 41: Histology and Cytology Market, Market Segmentation
Figure 42: Histology And Cytology Market, Saudi Arabia, Revenue Mix ($m), 2011
Figure 43: Histology And Cytology Market, Saudi Arabia, Segment Contribution (%), 2011
Figure 44: Histology And Cytology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 45: Histology And Cytology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 46: Histology And Cytology, Saudi Arabia, Company Share (%), 2011
Figure 47: Immuno Chemistry Market, Saudi Arabia, Revenue Mix ($m), 2011
Figure 48: Immuno Chemistry Market, Saudi Arabia, Segment Contribution (%), 2011
Figure 49: Immuno Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 50: Immuno Chemistry, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 51: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 52: Disease Specific Immunochemistry, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 53: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 54: Drugs of Abuse / Toxicology, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 55: Endocrinology Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 56: Endocrinology Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 57: Immunochemistry Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 58: Immunochemistry Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 59: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 60: Therapeutic Drug Monitoring, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 61: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 62: Immunochemistry Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 63: Immuno Chemistry, Saudi Arabia, Company Share (%), 2011
Figure 64: Infectious Immunology, Market Segmentation
Figure 65: Infectious Immunology Market, Saudi Arabia, Revenue Mix ($m), 2011
Figure 66: Infectious Immunology Market, Saudi Arabia, Segment Contribution (%), 2011
Figure 67: Infectious Immunology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 68: Infectious Immunology, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 69: Infectious Immunology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 70: Infectious Immunology Rapid Tests, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 71: Infectious Immunology, Saudi Arabia, Company Share (%), 2011
Figure 72: Microbiology Culture, Market Segmentation
Figure 73: Microbiology Culture Market, Saudi Arabia, Revenue Mix ($m), 2011
Figure 74: Microbiology Culture Market, Saudi Arabia, Segment Contribution (%), 2011
Figure 75: Microbiology Culture, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 76: Microbiology Culture, Saudi Arabia, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 77: Microbiology Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 78: Microbiology Analyzers, Saudi Arabia, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 79: Microbiology Culture, Saudi Arabia, Company Share (%), 2011
Figure 80: F. Hoffmann-La Roche Ltd., Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2011
Figure 81: Siemens Healthcare, Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2011
Figure 82: Abbott Laboratories, Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2011
Figure 83: Beckman Coulter, Inc., Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2011
Figure 84: bioMerieux S.A., Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2011
Figure 85: Becton, Dickinson and Company, Company Share (%),Saudi Arabia In Vitro Diagnostics Market, 2011

COMPANIES MENTIONED

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
Beckman Coulter, Inc.
bioMerieux S.A.
Becton, Dickinson and Company
Ortho-Clinical Diagnostics Inc.
Mindray Medical International Limited
Bio-Rad Laboratories, Inc.
Sysmex Corporation
Qiagen N.V.
Thermo Fisher Scientific Inc.
Grifols, S.A.
Horiba, Ltd.
PerkinElmer, Inc.
Life Technologies Corporation
Phadia AB
DiaSorin S.p.A
Gen-Probe Incorporated
Diagnostica Stago, Inc.
Chembio Diagnostics, Inc.
Alere Inc.
Immucor, Inc.
Hologic, Inc.

Ask Your Question

Saudi Arabia In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: